{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:53:14Z","timestamp":1779249194519,"version":"3.51.4"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02613-8","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T09:11:55Z","timestamp":1738228315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment"],"prefix":"10.1007","volume":"42","author":[{"given":"Ahmed I.","family":"Abulsoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaza H.","family":"Aly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nourhan M.","family":"Abdelmaksoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walaa A.","family":"El-Dakroury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7728-0923","authenticated-orcid":false,"given":"Mustafa Ahmed","family":"Abdel-Reheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Bakr","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehal I.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar Mohammed","family":"El Tabaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riham A.","family":"El-Shiekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0136-7096","authenticated-orcid":false,"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"7","key":"2613_CR1","first-page":"e27330","volume":"14","author":"SA Halaseh","year":"2022","unstructured":"Halaseh SA, Halaseh S, Alali Y, Ashour ME, Alharayzah MJ. A review of the etiology and epidemiology of bladder cancer: all you need to know. Cureus. 2022;14(7):e27330.","journal-title":"Cureus"},{"issue":"6","key":"2613_CR2","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3390\/cancers15061856","volume":"15","author":"D Thompson","year":"2023","unstructured":"Thompson D, Lawrentschuk N, Bolton D. New approaches to targeting epigenetic regulation in bladder cancer. Cancers. 2023;15(6):1856.","journal-title":"Cancers"},{"issue":"4","key":"2613_CR3","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/nar\/gkad1142","volume":"52","author":"C Diener","year":"2024","unstructured":"Diener C, Keller A, Meese E. The miRNA\u2013target interactions: an underestimated intricacy. Nucleic Acids Res. 2024;52(4):1544\u201357.","journal-title":"Nucleic Acids Res"},{"key":"2613_CR4","doi-asserted-by":"publisher","first-page":"110546","DOI":"10.1016\/j.biopha.2020.110546","volume":"130","author":"B Zhang","year":"2020","unstructured":"Zhang B, Tian L, Xie J, Chen G, Wang F. Targeting miRNAs by natural products: a new way for cancer therapy. Biomed Pharmacother. 2020;130:110546.","journal-title":"Biomed Pharmacother"},{"key":"2613_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/molecules25010063","volume":"25","author":"E Cione","year":"2020","unstructured":"Cione E, La Torre C, Cannataro R, Caroleo MC, Plastina P, Gallelli L. Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human MicroRNA modulation. Molecules. 2020;25:63.","journal-title":"Molecules"},{"issue":"4","key":"2613_CR6","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.ncrna.2024.06.003","volume":"9","author":"S Sumaira","year":"2024","unstructured":"Sumaira S, Vijayarathna S, Hemagirri M, Adnan M, Hassan MI, Patel M, Gupta R, Shanmugapriya, Chen Y, Gopinath SCB, Kanwar JR, Sasidharan S. Plant bioactive compounds driven microRNAs (miRNAs): a potential source and novel strategy targeting gene and cancer therapeutics. Non-coding RNA Res. 2024;9(4):1140\u201358.","journal-title":"Non-coding RNA Res"},{"key":"2613_CR7","doi-asserted-by":"publisher","first-page":"107100","DOI":"10.1016\/j.phrs.2024.107100","volume":"201","author":"L Huang","year":"2024","unstructured":"Huang L, Huang X-H, Yang X, Hu J-Q, Zhu Y-Z, Yan P-Y, Xie Y. Novel nano-drug delivery system for natural products and their application. Pharmacol Res. 2024;201:107100.","journal-title":"Pharmacol Res"},{"issue":"10","key":"2613_CR8","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s13346-024-01649-z","volume":"14","author":"T Andreani","year":"2024","unstructured":"Andreani T, Cheng R, Elbadri K, Ferro C, Menezes T, dos Santos MR, Pereira CM, Santos HA. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges. Drug Deliv Transl Res. 2024;14(10):2845\u2013916.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"2613_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ncrna8010010","volume":"8","author":"AL Leit\u00e3o","year":"2022","unstructured":"Leit\u00e3o AL, Enguita FJ. A structural view of miRNA biogenesis and function. Non-Coding RNA. 2022;8(1):10.","journal-title":"Non-Coding RNA"},{"key":"2613_CR10","first-page":"1","volume-title":"MicroRNA profiling: methods and protocols","author":"A Vishnoi","year":"2023","unstructured":"Vishnoi A, Rani S. miRNA biogenesis and regulation of diseases: an updated overview. In: Rani S, editor. MicroRNA profiling: methods and protocols. New York: Springer; 2023. p. 1\u201312."},{"issue":"4","key":"2613_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.tig.2021.10.002","volume":"38","author":"MP Dragomir","year":"2022","unstructured":"Dragomir MP, Knutsen E, Calin GA. Classical and noncanonical functions of miRNAs in cancers. Trends Genet. 2022;38(4):379\u201394.","journal-title":"Trends Genet"},{"issue":"1","key":"2613_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1134\/S106816202001015X","volume":"46","author":"IA Zaporozhchenko","year":"2020","unstructured":"Zaporozhchenko IA, Rykova EY, Laktionov PP. The fundamentals of miRNA biology: structure, biogenesis, and regulatory functions. Russ J Bioorg Chem. 2020;46(1):1\u201313.","journal-title":"Russ J Bioorg Chem"},{"issue":"1","key":"2613_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15(1):25\u201341.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2613_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.urolonc.2010.04.008","volume":"28","author":"DJ McConkey","year":"2010","unstructured":"McConkey DJ, Lee S, Choi W, Tran M, Majewski T, Lee S, Siefker-Radtke A, Dinney C, Czerniak B. Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression. Urol Oncol: Semin Orig Investig. 2010;28(4):429\u201340.","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"2613_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-1-4939-7234-0_23","volume-title":"Urothelial carcinoma: methods and protocols","author":"A Sathe","year":"2018","unstructured":"Sathe A, Nawroth R. Targeting the PI3K\/AKT\/mTOR pathway in bladder cancer. In: Schulz WA, Hoffmann MJ, Niegisch G, editors. Urothelial carcinoma: methods and protocols. New York: Springer; 2018. p. 335\u201350."},{"key":"2613_CR16","doi-asserted-by":"publisher","first-page":"819128","DOI":"10.3389\/fonc.2022.819128","volume":"12","author":"Y Peng","year":"2022","unstructured":"Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway? Front Oncol. 2022;12:819128.","journal-title":"Front Oncol"},{"issue":"7","key":"2613_CR17","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1158\/1535-7163.MCT-17-0464","volume":"17","author":"B Bockorny","year":"2018","unstructured":"Bockorny B, Rusan M, Chen W, Liao RG, Li Y, Piccioni F, Wang J, Tan L, Thorner AR, Li T, Zhang Y, Miao C, Ovesen T, Shapiro GI, Kwiatkowski DJ, Gray NS, Meyerson M, Hammerman PS, Bass AJ. RAS\u2013MAPK reactivation facilitates acquired resistance in FGFR1-amplified lung cancer and underlies a rationale for upfront FGFR\u2013MEK blockade. Mol Cancer Ther. 2018;17(7):1526\u201339.","journal-title":"Mol Cancer Ther"},{"key":"2613_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/CBM-2012-0254","volume":"10","author":"S Ouerhani","year":"2012","unstructured":"Ouerhani S, Elgaaied ABA. The mutational spectrum of HRAS, KRAS, NRAS and FGFR3 genes in bladder cancer. Cancer Biomark. 2012;10:259\u201366.","journal-title":"Cancer Biomark"},{"issue":"2","key":"2613_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2174\/157489209788452812","volume":"4","author":"PP Dangle","year":"2009","unstructured":"Dangle PP, Zaharieva B, Jia H, Pohar KS. Ras-MAPK pathway as a therapeutic target in cancer\u2014emphasis on bladder cancer. Recent Pat Anti-Cancer Drug Discov. 2009;4(2):125\u201336.","journal-title":"Recent Pat Anti-Cancer Drug Discov"},{"issue":"1","key":"2613_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8(1):455.","journal-title":"Signal Transduct Target Ther"},{"key":"2613_CR21","doi-asserted-by":"publisher","first-page":"102530","DOI":"10.1016\/j.ctrv.2023.102530","volume":"115","author":"CM Ascione","year":"2023","unstructured":"Ascione CM, Napolitano F, Esposito D, Servetto A, Belli S, Santaniello A, Scagliarini S, Crocetto F, Bianco R, Formisano L. Role of FGFR3 in bladder cancer: treatment landscape and future challenges. Cancer Treat Rev. 2023;115:102530.","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"2613_CR22","first-page":"1626","volume":"29","author":"G-S Choi","year":"2014","unstructured":"Choi G-S, Shin YS, Kim J-H, Choi SY, Lee S-K, Nam Y-H, Lee Y-M, Park H-S. Prevalence and risk factors for depression in Korean adult patients with asthma: is there a difference between elderly and non-elderly patients? jkms. 2014;29(12):1626\u201331.","journal-title":"jkms"},{"issue":"3","key":"2613_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.juro.2015.08.082","volume":"195","author":"A Sathe","year":"2016","unstructured":"Sathe A, Koshy N, Schmid SC, Thalgott M, Schwarzenb\u00f6ck SM, Krause BJ, Holm PS, Gschwend JE, Retz M, Nawroth R. CDK4\/6 inhibition controls proliferation of bladder cancer and transcription of RB1. J Urol. 2016;195(3):771\u20139.","journal-title":"J Urol"},{"issue":"23","key":"2613_CR24","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1002\/cncr.30219","volume":"122","author":"NB Desai","year":"2016","unstructured":"Desai NB, Scott SN, Zabor EC, Cha EK, Hreiki J, Sfakianos JP, Ramirez R, Bagrodia A, Rosenberg JE, Bajorin DF, Berger MF, Bochner BH, Zelefsky MJ, Kollmeier MA, Ostrovnaya I, Al-Ahmadie HA, Solit DB, Iyer G. Genomic characterization of response to chemoradiation in urothelial bladder cancer. Cancer. 2016;122(23):3715\u201323.","journal-title":"Cancer"},{"issue":"5","key":"2613_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2021.12.004","volume":"81","author":"M Mossanen","year":"2022","unstructured":"Mossanen M, Carvalho FLF, Muralidhar V, Preston MA, Reardon B, Conway JR, Curran C, Freeman D, Sha S, Sonpavde G, Hirsch M, Kibel AS, Van Allen EM, Mouw KW. Genomic features of muscle-invasive bladder cancer arising after prostate radiotherapy. Eur Urol. 2022;81(5):466\u201373.","journal-title":"Eur Urol"},{"key":"2613_CR26","doi-asserted-by":"publisher","first-page":"103539","DOI":"10.1016\/j.critrevonc.2021.103539","volume":"168","author":"S Genta","year":"2021","unstructured":"Genta S, Martorana F, Stathis A, Colombo I. Targeting the DNA damage response: PARP inhibitors and new perspectives in the landscape of cancer treatment. Crit Rev Oncol Hematol. 2021;168:103539.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"2613_CR27","doi-asserted-by":"publisher","first-page":"a012716","DOI":"10.1101\/cshperspect.a012716","volume":"5","author":"A Marechal","year":"2013","unstructured":"Marechal A, Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol. 2013;5(9):a012716.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"12","key":"2613_CR28","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/cells13121063","volume":"13","author":"MS Ilieva","year":"2024","unstructured":"Ilieva MS. Non-coding RNAs in neurological and neuropsychiatric disorders: unraveling the hidden players in disease pathogenesis. Cells. 2024;13(12):1063.","journal-title":"Cells"},{"key":"2613_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-023-03133-z","volume":"23","author":"S Akhlaghitehrani","year":"2023","unstructured":"Akhlaghitehrani S, Mohammed SH, Yasamineh S, Kalajahi HG, Gholizadeh O. Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. Cancer Cell Int. 2023;23:284.","journal-title":"Cancer Cell Int"},{"key":"2613_CR30","doi-asserted-by":"publisher","first-page":"109886","DOI":"10.1016\/j.cellsig.2020.109886","volume":"79","author":"G Wu","year":"2021","unstructured":"Wu G, Weng W, Xia P, Yan S, Zhong C, Xie L, Xie Y, Fan G. Wnt signalling pathway in bladder cancer. Cell Signal. 2021;79:109886.","journal-title":"Cell Signal"},{"key":"2613_CR31","doi-asserted-by":"crossref","unstructured":"Uzuner E, Ulu GT, G\u00fcrler SB, Baran Y. The role of MiRNA in cancer: pathogenesis, diagnosis, and treatment, miRNomics: MicroRNA Biol Comput Anal. 2022;375\u2013422.","DOI":"10.1007\/978-1-0716-1170-8_18"},{"issue":"5","key":"2613_CR32","first-page":"5549","volume":"18","author":"Z-S Ding","year":"2019","unstructured":"Ding Z-S, He Y-H, Deng Y-S, Peng P-X, Wang J-F, Chen X, Zhao P-Y, Zhou X-F. MicroRNA-34a inhibits bladder cancer cell migration and invasion, and upregulates PTEN expression. Oncol Lett. 2019;18(5):5549\u201354.","journal-title":"Oncol Lett"},{"issue":"3","key":"2613_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3892\/or.2020.7910","volume":"45","author":"KY Chou","year":"2021","unstructured":"Chou KY, Chang AC, Tsai TF, Lin YC, Chen HE, Ho CY, Chen PC, Hwang TIS. MicroRNA-34a-5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase-2 silencing. Oncol Rep. 2021;45(3):911\u201320.","journal-title":"Oncol Rep"},{"issue":"1","key":"2613_CR34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1186\/s13046-014-0115-4","volume":"33","author":"G Yu","year":"2014","unstructured":"Yu G, Yao W, Xiao W, Li H, Xu H, Lang B. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44. J Exp Clin Cancer Res. 2014;33(1):779.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2613_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3892\/ijo.2023.5514","volume":"62","author":"TIS Hwang","year":"2023","unstructured":"Hwang TIS, Cuiu Y-C, Chen Y-C, Chen P-C, Tsai T-F, Chou K-Y, Ho C-Y, Chen H-E, Chang P-H, Chang A-C. Tumor suppressive functions of hsa-miR-34a on cell cycle, migration and protective autophagy in bladder cancer. Int J Oncol. 2023;62(5):66.","journal-title":"Int J Oncol"},{"issue":"1","key":"2613_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-4598-13-8","volume":"13","author":"H Li","year":"2014","unstructured":"Li H, Yu G, Shi R, Lang B, Chen X, Xia D, Xiao H, Guo X, Guan W, Ye Z, Xiao W, Xu H. Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Mol Cancer. 2014;13(1):8.","journal-title":"Mol Cancer"},{"issue":"18","key":"2613_CR37","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1111\/febs.12417","volume":"280","author":"Y Guo","year":"2013","unstructured":"Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang Z, Qiu F, Lin J. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH 2 and regulating W nt signaling. FEBS J. 2013;280(18):4531\u20138.","journal-title":"FEBS J"},{"issue":"2","key":"2613_CR38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/bjc.2015.195","volume":"113","author":"R Matsushita","year":"2015","unstructured":"Matsushita R, Seki N, Chiyomaru T, Inoguchi S, Ishihara T, Goto Y, Nishikawa R, Mataki H, Tatarano S, Itesako T, Nakagawa M, Enokida H. Tumour-suppressive microRNA-144-5p directly targets CCNE1\/2 as potential prognostic markers in bladder cancer. Br J Cancer. 2015;113(2):282\u20139.","journal-title":"Br J Cancer"},{"issue":"1","key":"2613_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/carcin\/bgr239","volume":"33","author":"H Hirata","year":"2012","unstructured":"Hirata H, Hinoda Y, Ueno K, Shahryari V, Tabatabai ZL, Dahiya R. MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis. 2012;33(1):41\u20138.","journal-title":"Carcinogenesis"},{"issue":"9","key":"2613_CR40","doi-asserted-by":"publisher","first-page":"12177","DOI":"10.1096\/fj.202000347R","volume":"34","author":"Q Li","year":"2020","unstructured":"Li Q, Huyan T, Cai S, Huang Q, Zhang M, Peng H, Zhang Y, Liu N, Zhang W. The role of exosomal miR-375-3p: a potential suppressor in bladder cancer via the Wnt\/\u03b2-catenin pathway. FASEB J. 2020;34(9):12177\u201396.","journal-title":"FASEB J"},{"key":"2613_CR41","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fphar.2020.00605","volume":"11","author":"Y-R Shi","year":"2020","unstructured":"Shi Y-R, Wu Z, Xiong K, Liao Q-J, Ye X, Yang P, Zu X-B. Circular RNA circKIF4A sponges miR-375\/1231 to promote bladder cancer progression by upregulating NOTCH2 expression. Front Pharmacol. 2020;11:605.","journal-title":"Front Pharmacol"},{"issue":"18","key":"2613_CR42","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1074\/jbc.RA118.001689","volume":"293","author":"X Huang","year":"2018","unstructured":"Huang X, Zhu H, Gao Z, Li J, Zhuang J, Dong Y, Shen B, Li M, Zhou H, Guo H. Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p. J Biol Chem. 2018;293(18):6693\u2013706.","journal-title":"J Biol Chem"},{"key":"2613_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cbi.2019.01.015","volume":"300","author":"X Xie","year":"2019","unstructured":"Xie X, Pan J, Han X, Chen W. Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3\/Wnt\/\u03b2-catenin signaling. Chem Biol Interact. 2019;300:73\u201381.","journal-title":"Chem Biol Interact"},{"key":"2613_CR44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cbi.2019.05.042","volume":"308","author":"H Tian","year":"2019","unstructured":"Tian H, Wang X, Lu J, Tian W, Chen P. MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt\/\u03b2-catenin signaling. Chem Biol Interact. 2019;308:244\u201351.","journal-title":"Chem Biol Interact"},{"key":"2613_CR45","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s11255-018-1959-x","volume":"50","author":"J Cao","year":"2018","unstructured":"Cao J, Wang Q, Wu G, Li S, Wang Q. miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a. Int Urol Nephrol. 2018;50:1811\u20139.","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"2613_CR46","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1159\/000491911","volume":"48","author":"X Chen","year":"2018","unstructured":"Chen X, Jia C, Jia C, Jin X, Gu X. MicroRNA-374a inhibits aggressive tumor biological behavior in bladder carcinoma by suppressing Wnt\/\u03b2-catenin signaling. Cell Physiol Biochem. 2018;48(2):815\u201326.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"2613_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13577-019-00285-x","volume":"33","author":"S Liu","year":"2020","unstructured":"Liu S, Chen Q, Wang Y. MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K\/AKT pathway. Hum Cell. 2020;33(1):185\u201394.","journal-title":"Hum Cell"},{"issue":"8","key":"2613_CR48","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/ijc.25509","volume":"128","author":"L Huang","year":"2011","unstructured":"Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo Z, Dong W, Huang J, Lin T. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer. 2011;128(8):1758\u201369.","journal-title":"Int J Cancer"},{"issue":"1","key":"2613_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2018.11.005","volume":"375","author":"F Wang","year":"2019","unstructured":"Wang F, Wu D, Chen J, Chen S, He F, Fu H, Wu Q, Liu S, Li X, Wang W. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b\/Smad2 axis. Exp Cell Res. 2019;375(1):1\u201310.","journal-title":"Exp Cell Res"},{"issue":"1","key":"2613_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12672-022-00512-2","volume":"13","author":"W Huang","year":"2022","unstructured":"Huang W, Zhang C, Xiong S, Zhou X, Wang G, Guo J. miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway. Discov Oncol. 2022;13(1):57.","journal-title":"Discov Oncol"},{"issue":"1","key":"2613_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13046-019-1136-9","volume":"38","author":"W Mao","year":"2019","unstructured":"Mao W, Huang X, Wang L, Zhang Z, Liu M, Li Y, Luo M, Yao X, Fan J, Geng J. Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression. J Exp Clin Cancer Res. 2019;38(1):169.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"2613_CR52","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.7314\/APJCP.2013.14.7.4127","volume":"14","author":"Q-Q Jiang","year":"2013","unstructured":"Jiang Q-Q, Liu B, Yuan T. MicroRNA-16 inhibits bladder cancer proliferation by targeting Cyclin D1. Asian Pac J Cancer Prev. 2013;14(7):4127\u201330.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"2613_CR53","doi-asserted-by":"publisher","first-page":"14298","DOI":"10.3390\/ijms150814298","volume":"15","author":"W Zuo","year":"2014","unstructured":"Zuo W, Wang Z-Z, Xue J. Artesunate induces apoptosis of bladder cancer cells by miR-16 regulation of COX-2 expression. Int J Mol Sci. 2014;15(8):14298\u2013312.","journal-title":"Int J Mol Sci"},{"key":"2613_CR54","unstructured":"Yu Q-F, Liu P, Li Z-Y, Zhang C-F, Chen S-Q, Li Z-H, Zhang G-Y, Li J-C. MiR-103\/107 induces tumorigenicity in bladder cancer cell by suppressing PTEN. Eur Rev Med Pharmacol Sci. 2018;22(24)."},{"issue":"1","key":"2613_CR55","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/ijms18010078","volume":"18","author":"M Lv","year":"2016","unstructured":"Lv M, Zhong Z, Chi H, Huang M, Jiang R, Chen J. Genome-wide screen of miRNAs and targeting mRNAs reveals the negatively regulatory effect of miR-130b-3p on PTEN by PI3K and integrin \u03b21 signaling pathways in bladder carcinoma. Int J Mol Sci. 2016;18(1):78.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2613_CR56","doi-asserted-by":"publisher","first-page":"20574","DOI":"10.1038\/srep20574","volume":"6","author":"H Egawa","year":"2016","unstructured":"Egawa H, Jingushi K, Hirono T, Ueda Y, Kitae K, Nakata W, Fujita K, Uemura M, Nonomura N, Tsujikawa K. The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN. Sci Rep. 2016;6(1):20574.","journal-title":"Sci Rep"},{"issue":"10","key":"2613_CR57","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1089\/dna.2015.2868","volume":"34","author":"M Lei","year":"2015","unstructured":"Lei M, Xie W, Sun E, Sun Y, Tian D, Liu C, Han R, Li N, Liu M, Han R. microRNA-21 regulates cell proliferation and migration and cross talk with PTEN and p53 in bladder cancer. DNA Cell Biol. 2015;34(10):626\u201332.","journal-title":"DNA Cell Biol"},{"key":"2613_CR58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s13277-014-2617-2","volume":"36","author":"X Yang","year":"2015","unstructured":"Yang X, Cheng Y, Li P, Tao J, Deng X, Zhang X, Gu M, Lu Q, Yin C. A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN\/PI3K\/AKT\/mTOR axis. Tumor Biol. 2015;36:383\u201391.","journal-title":"Tumor Biol"},{"issue":"4","key":"2613_CR59","first-page":"4223","volume":"16","author":"H Wang","year":"2018","unstructured":"Wang H, Hu Z, Chen L. Enhanced plasma miR-26a-5p promotes the progression of bladder cancer via targeting PTEN. Oncol Lett. 2018;16(4):4223\u20138.","journal-title":"Oncol Lett"},{"issue":"2","key":"2613_CR60","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.bbrc.2017.01.019","volume":"483","author":"M Tan","year":"2017","unstructured":"Tan M, Mu X, Liu Z, Tao L, Wang J, Ge J, Qiu J. microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog. Biochem Biophys Res Commun. 2017;483(2):867\u201373.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2613_CR61","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.1038\/emm.2017.239","volume":"50","author":"X-W Mao","year":"2018","unstructured":"Mao X-W, Xiao J-Q, Li Z-Y, Zheng Y-C, Zhang N. Effects of microRNA-135a on the epithelial\u2013mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3\u03b2 through the Wnt\/\u03b2-catenin signaling pathway. Exp Mol Med. 2018;50(1):e429\u2013e429.","journal-title":"Exp Mol Med"},{"issue":"3","key":"2613_CR62","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1096\/fj.201901764R","volume":"34","author":"Z Chen","year":"2020","unstructured":"Chen Z, Yang L, Chen L, Li J, Zhang F, Xing Y, Zhao J. miR-190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma. FASEB J. 2020;34(3):4072\u201384.","journal-title":"FASEB J"},{"issue":"12","key":"2613_CR63","doi-asserted-by":"publisher","first-page":"16295","DOI":"10.1007\/s13277-016-5460-9","volume":"37","author":"H Wang","year":"2016","unstructured":"Wang H, Ke C, Ma X, Zhao Q, Yang M, Zhang W, Wang J. MicroRNA-92 promotes invasion and chemoresistance by targeting GSK3\u03b2 and activating Wnt signaling in bladder cancer cells. Tumor Biol. 2016;37(12):16295\u2013304.","journal-title":"Tumor Biol"},{"issue":"11","key":"2613_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0155-5","volume":"50","author":"Z Ou","year":"2018","unstructured":"Ou Z, Wang Y, Chen J, Tao L, Zuo L, Sahasrabudhe D, Joseph J, Wang L, Yeh S. Estrogen receptor \u03b2 promotes bladder cancer growth and invasion via alteration of miR-92a\/DAB2IP signals. Exp Mol Med. 2018;50(11):1\u201311.","journal-title":"Exp Mol Med"},{"key":"2613_CR65","unstructured":"Chen D, Li S-G, Chen J-Y, Xiao M. MiR-183 maintains canonical Wnt signaling activity and regulates growth and apoptosis in bladder cancer via targeting AXIN2. Eur Rev Med Pharmacol Sci 2018;22(15)."},{"issue":"9","key":"2613_CR66","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/s41388-019-1120-z","volume":"39","author":"R Yang","year":"2020","unstructured":"Yang R, Xu J, Hua X, Tian Z, Xie Q, Li J, Jiang G, Cohen M, Sun H, Huang C. Overexpressed miR-200a promotes bladder cancer invasion through direct regulating Dicer\/miR-16\/JNK2\/MMP-2 axis. Oncogene. 2020;39(9):1983\u201396.","journal-title":"Oncogene"},{"issue":"1","key":"2613_CR67","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-016-0376-9","volume":"10","author":"C Huang","year":"2017","unstructured":"Huang C, Zeng X, Jiang G, Liao X, Liu C, Li J, Jin H, Zhu J, Sun H, Wu X-R, Huang C. XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell. J Hematol Oncol. 2017;10(1):6.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2613_CR68","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1039\/D3RA06355K","volume":"14","author":"EB Abdelazim","year":"2024","unstructured":"Abdelazim EB, Abed T, Goher SS, Alya SH, El-Nashar HA, El-Moslamy SH, El-Fakharany EM, Abdul-Baki EA, Shakweer MM, Eissa NG. In vitro and in vivo studies of Syzygium cumini-loaded electrospun PLGA\/PMMA\/collagen nanofibers for accelerating topical wound healing. RSC Adv. 2024;14(1):101\u201317.","journal-title":"RSC Adv"},{"issue":"5","key":"2613_CR69","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/molecules28052193","volume":"28","author":"SH Aly","year":"2023","unstructured":"Aly SH, Kandil NH, Hemdan RM, Kotb SS, Zaki SS, Abdelaziz OM, AbdelRazek MM, Almahli H, El Hassab MA, Al-Rashood ST. GC\/MS profiling of the essential oil and lipophilic extract of Moricandia sinaica Boiss. and evaluation of their cytotoxic and antioxidant activities. Molecules. 2023;28(5):2193.","journal-title":"Molecules"},{"key":"2613_CR70","doi-asserted-by":"crossref","unstructured":"Aly SH, Elbadry AM, Doghish AS, El-Nashar HA. Unveiling the pharmacological potential of plant triterpenoids in breast cancer management: an updated review. Naunyn-Schmiedeberg's Arch Pharmacol 2024;1\u201326.","DOI":"10.1007\/s00210-024-03054-2"},{"key":"2613_CR71","doi-asserted-by":"publisher","first-page":"128793","DOI":"10.1016\/j.ijbiomac.2023.128793","volume":"258","author":"SS Goher","year":"2024","unstructured":"Goher SS, Aly SH, Abu-Serie MM, El-Moslamy SH, Allam AA, Diab NH, Hassanein KM, Eissa RA, Eissa NG, Elsabahy M. Electrospun Tamarindus indica-loaded antimicrobial PMMA\/cellulose acetate\/PEO nanofibrous scaffolds for accelerated wound healing: in-vitro and in-vivo assessments. Int J Biol Macromol. 2024;258:128793.","journal-title":"Int J Biol Macromol"},{"key":"2613_CR72","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00432-015-2089-9","volume":"142","author":"M Schubert","year":"2016","unstructured":"Schubert M, Junker K, Heinzelmann J. Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development? J Cancer Res Clin Oncol. 2016;142:1673\u201395.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2613_CR73","first-page":"804510","volume":"2014","author":"NH Phuah","year":"2014","unstructured":"Phuah NH, Nagoor NH. Regulation of microRNAs by natural agents: new strategies in cancer therapies. Biomed Res Int. 2014;2014(1):804510.","journal-title":"Biomed Res Int"},{"issue":"10","key":"2613_CR74","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2174\/13894501113149990189","volume":"14","author":"S Sethi","year":"2013","unstructured":"Sethi S, Li Y, Sarkar FH. Regulating miRNA by natural agents as a new strategy for cancer treatment. Curr Drug Targets. 2013;14(10):1167\u201374.","journal-title":"Curr Drug Targets"},{"issue":"7","key":"2613_CR75","first-page":"3531","volume":"12","author":"AM Alnuqaydan","year":"2020","unstructured":"Alnuqaydan AM. Targeting micro-RNAs by natural products: a novel future therapeutic strategy to combat cancer. Am J Transl Res. 2020;12(7):3531.","journal-title":"Am J Transl Res"},{"key":"2613_CR76","doi-asserted-by":"crossref","unstructured":"Zengin G, Yagi S, Eldahshan OA, Singab AN, Selvi S, Rodrigues MJ, Custodio L, Dall\u2019Acqua S, Ponnaiya SKM,  Aly SH. Decoding chemical profiles and biological activities of aerial parts and roots of Eryngium thorifolium Boiss by HPLC-MS\/MS, GC-MS and in vitro chemical assays. Food Biosci. 2024;104556.","DOI":"10.1016\/j.fbio.2024.104556"},{"issue":"19","key":"2613_CR77","doi-asserted-by":"publisher","first-page":"6737","DOI":"10.1080\/10408398.2023.2173720","volume":"64","author":"FR Saber","year":"2024","unstructured":"Saber FR, Munekata PE, Rizwan K, El-Nashar HA, Fahmy NM, Aly SH, El-Shazly M, Bouyahya A, Lorenzo JM. Family Myrtaceae: the treasure hidden in the complex\/diverse composition. Crit Rev Food Sci Nutr. 2024;64(19):6737\u201355.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"7","key":"2613_CR78","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.3390\/molecules28072994","volume":"28","author":"SH Aly","year":"2023","unstructured":"Aly SH, Elissawy AM, Mahmoud AM, El-Tokhy FSE, Mageed SSA, Almahli H, Al-Rashood ST, Binjubair FA, Hassab MAE, Eldehna WM. Synergistic effect of Sophora japonica and Glycyrrhiza glabra flavonoid-rich fractions on wound healing: in vivo and molecular docking studies. Molecules. 2023;28(7):2994.","journal-title":"Molecules"},{"issue":"4","key":"2613_CR79","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2174\/1574892816666211213090623","volume":"17","author":"HA El-Nashar","year":"2022","unstructured":"El-Nashar HA, Aly SH, Ahmadi A, El-Shazly M. The impact of polyphenolics in the management of breast cancer: mechanistic aspects and recent patents. Recent Pat Anti-Cancer Drug Discov. 2022;17(4):358\u201379.","journal-title":"Recent Pat Anti-Cancer Drug Discov"},{"key":"2613_CR80","doi-asserted-by":"publisher","first-page":"103152","DOI":"10.1016\/j.micron.2021.103152","volume":"151","author":"BS Adami","year":"2021","unstructured":"Adami BS, Diz FM, Gon\u00e7alves GPO, Reghelin CK, Scherer M, Dutra AP, Papal\u00e9o RM, de Oliveira JR, Morrone FB, Wieck A. Morphological and mechanical changes induced by quercetin in human T24 bladder cancer cells. Micron. 2021;151:103152.","journal-title":"Micron"},{"issue":"2","key":"2613_CR81","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/UROS.UROS_22_18","volume":"30","author":"T-F Tsai","year":"2019","unstructured":"Tsai T-F, Thomas I, Hwang S, Lin J-F, Chen H-E, Yang S-C, Lin Y-C, Chou K-Y. Suppression of quercetin-induced autophagy enhances cytotoxicity through elevating apoptotic cell death in human bladder cancer cells. Urol Sci. 2019;30(2):58\u201366.","journal-title":"Urol Sci"},{"key":"2613_CR82","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11626-019-00363-2","volume":"55","author":"Y-H Lee","year":"2019","unstructured":"Lee Y-H, Tuyet P-T. Synthesis and biological evaluation of quercetin\u2013zinc (II) complex for anti-cancer and anti-metastasis of human bladder cancer cells. In Vitro Cell Dev Biol Anim. 2019;55:395\u2013404.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"24","key":"2613_CR83","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1080\/14786419.2020.1795853","volume":"35","author":"SH Aly","year":"2021","unstructured":"Aly SH, Elissawy AM, Fayez AM, Eldahshan OA, Elshanawany MA, Singab ANB. Neuroprotective effects of Sophora secundiflora, Sophora tomentosa leaves and formononetin on scopolamine-induced dementia. Nat Prod Res. 2021;35(24):5848\u201352.","journal-title":"Nat Prod Res"},{"issue":"3","key":"2613_CR84","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.plaphy.2007.12.009","volume":"46","author":"J-L Ferrer","year":"2008","unstructured":"Ferrer J-L, Austin M, Stewart C Jr, Noel J. Structure and function of enzymes involved in the biosynthesis of phenylpropanoids. Plant Physiol Biochem. 2008;46(3):356\u201370.","journal-title":"Plant Physiol Biochem"},{"issue":"6","key":"2613_CR85","first-page":"435","volume":"37","author":"L Du","year":"2022","unstructured":"Du L, Zhang L, Sun F. Puerarin inhibits the progression of bladder cancer by regulating circ_0020394\/miR-328-3p\/NRBP1 axis. Cancer Biother Radiopharm. 2022;37(6):435\u201350.","journal-title":"Cancer Biother Radiopharm"},{"issue":"8","key":"2613_CR86","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3727\/096504018X15178736525106","volume":"26","author":"X Liu","year":"2018","unstructured":"Liu X, Li S, Li Y, Cheng B, Tan B, Wang G. Puerarin inhibits proliferation and induces apoptosis by upregulation of miR-16 in bladder cancer cell line T24. Oncol Res. 2018;26(8):1227.","journal-title":"Oncol Res"},{"issue":"3","key":"2613_CR87","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1039\/C6FO01535B","volume":"8","author":"Y Wu","year":"2017","unstructured":"Wu Y, Zhang X, Li Z, Yan H, Qin J, Li T. Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN. Food Funct. 2017;8(3):1061\u20136.","journal-title":"Food Funct"},{"issue":"10","key":"2613_CR88","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1158\/1940-6207.CAPR-11-0267","volume":"4","author":"S Saini","year":"2011","unstructured":"Saini S, Arora S, Majid S, Shahryari V, Chen Y, Deng G, Yamamura S, Ueno K, Dahiya R. Curcumin modulates MicroRNA-203\u2013mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res. 2011;4(10):1698\u2013709.","journal-title":"Cancer Prev Res"},{"issue":"06","key":"2613_CR89","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1142\/S0192415X18500714","volume":"46","author":"K Wang","year":"2018","unstructured":"Wang K, Tan S-L, Lu Q, Xu R, Cao J, Wu S-Q, Wang Y-H, Zhao X-K, Zhong Z-H. Curcumin suppresses microRNA-7641-mediated regulation of p16 expression in bladder cancer. Am J Chin Med. 2018;46(06):1357\u201368.","journal-title":"Am J Chin Med"},{"key":"2613_CR90","doi-asserted-by":"publisher","first-page":"154947","DOI":"10.1016\/j.phymed.2023.154947","volume":"119","author":"F-T Hsu","year":"2023","unstructured":"Hsu F-T, Liu W-L, Lee S-R, Jeng L-B, Chen J-H. Unveiling nature\u2019s potential weapon: Magnolol\u2019s role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-\u03b4\/ERK axis. Phytomedicine. 2023;119:154947.","journal-title":"Phytomedicine"},{"key":"2613_CR91","doi-asserted-by":"crossref","unstructured":"Al-Hetty HRAK, Ahmed AT, Saleem HM, Abdulhadi HL, Muhammed TM, Ali LH. Cellular and molecular mechanisms of action of epigallocatechin gallate on bladder cancer: a comprehensive systematic review. PharmaNutrition 2024;28.","DOI":"10.1016\/j.phanu.2024.100392"},{"issue":"3","key":"2613_CR92","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ptr.5267","volume":"29","author":"B Zhou","year":"2015","unstructured":"Zhou B, Yi H, Tan J, Wu Y, Liu G, Qiu Z. Anti-proliferative effects of polyphenols from pomegranate rind (Punica granatum L.) on EJ bladder cancer cells via regulation of p53\/miR-34a Axis. Phytother Res. 2015;29(3):415\u201322.","journal-title":"Phytother Res"},{"issue":"4","key":"2613_CR93","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3892\/mmr.2014.1950","volume":"9","author":"C Zhou","year":"2014","unstructured":"Zhou C, Ding J, Wu Y. Resveratrol induces apoptosis of bladder cancer cells via miR-21 regulation of the Akt\/Bcl-2 signaling pathway. Mol Med Rep. 2014;9(4):1467\u201373.","journal-title":"Mol Med Rep"},{"issue":"10","key":"2613_CR94","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1002\/mnfr.201400104","volume":"58","author":"GV Bricker","year":"2014","unstructured":"Bricker GV, Riedl KM, Ralston RA, Tober KL, Oberyszyn TM, Schwartz SJ. Isothiocyanate metabolism, distribution, and interconversion in mice following consumption of thermally processed broccoli sprouts or purified sulforaphane. Mol Nutr Food Res. 2014;58(10):1991\u20132000.","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"2613_CR95","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jnutbio.2012.08.004","volume":"24","author":"Y Shan","year":"2013","unstructured":"Shan Y, Zhang L, Bao Y, Li B, He C, Gao M, Feng X, Xu W, Zhang X, Wang S. Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2\/MMP2, 9\/Snail, ZEB1 and miR-200c\/ZEB1 pathways in human bladder cancer cells. J Nutr Biochem. 2013;24(6):1062\u20139.","journal-title":"J Nutr Biochem"},{"issue":"5","key":"2613_CR96","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/ffj.3672","volume":"36","author":"D Joulain","year":"2021","unstructured":"Joulain D. Jasminum grandiflorum flowers\u2014phytochemical complexity and its capture in extracts: a review. Flavour Fragr J. 2021;36(5):526\u201353.","journal-title":"Flavour Fragr J"},{"issue":"3","key":"2613_CR97","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/bph.12501","volume":"171","author":"Y Wang","year":"2014","unstructured":"Wang Y, Xiang W, Wang M, Huang T, Xiao X, Wang L, Tao D, Dong L, Zeng F, Jiang G. Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH 2 expression by miR-101. Br J Pharmacol. 2014;171(3):618\u201335.","journal-title":"Br J Pharmacol"},{"key":"2613_CR98","doi-asserted-by":"publisher","first-page":"114575","DOI":"10.1016\/j.bcp.2021.114575","volume":"188","author":"Y Xia","year":"2021","unstructured":"Xia Y, Chen S, Cui J, Wang Y, Liu X, Shen Y, Gong L, Jiang X, Wang W, Zhu Y. Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p. Biochem Pharmacol. 2021;188:114575.","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"2613_CR99","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1159\/000447878","volume":"39","author":"Y Zhi","year":"2016","unstructured":"Zhi Y, Pan J, Shen W, He P, Zheng J, Zhou X, Lu G, Chen Z, Zhou Z. Ginkgolide B inhibits human bladder cancer cell migration and invasion through microRNA-223-3p. Cell Physiol Biochem. 2016;39(5):1787\u201394.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"2613_CR100","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2013.02.032","volume":"334","author":"F Aqil","year":"2013","unstructured":"Aqil F, Munagala R, Jeyabalan J, Vadhanam MV. Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett. 2013;334(1):133\u201341.","journal-title":"Cancer Lett"},{"issue":"1","key":"2613_CR101","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1039\/C6FO01475E","volume":"8","author":"JA Dom\u00ednguez-Avila","year":"2017","unstructured":"Dom\u00ednguez-Avila JA, Wall-Medrano A, Velderrain-Rodr\u00edguez GR, Chen CO, Salazar-L\u00f3pez NJ, Robles-S\u00e1nchez M, Gonz\u00e1lez-Aguilar GA. Gastrointestinal interactions, absorption, splanchnic metabolism and pharmacokinetics of orally ingested phenolic compounds. Food Funct. 2017;8(1):15\u201338.","journal-title":"Food Funct"},{"key":"2613_CR102","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.2147\/DDDT.S447496","volume":"18","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liang Y, Yuhong J, Xin P, Han JL, Du Y, Yu X, Zhu R, Zhang M, Chen W, Ma Y. Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs. Drug Des Devel Ther. 2024;18:1469\u201395.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"2613_CR103","first-page":"35","volume":"5","author":"R Kumar","year":"2018","unstructured":"Kumar R, Sharma M. Herbal nanomedicine interactions to enhance pharmacokinetics, pharmacodynamics, and therapeutic index for better bioavailability and biocompatibility of herbal formulations. J Mater NanoSci. 2018;5(1):35\u201360.","journal-title":"J Mater NanoSci"},{"issue":"12","key":"2613_CR104","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/medicina55120768","volume":"55","author":"H-Y Lee","year":"2019","unstructured":"Lee H-Y, Chen Y-J, Chang W-A, Li W-M, Ke H-L, Wu W-J, Kuo P-L. Effects of epigallocatechin gallate (EGCG) on urinary bladder urothelial carcinoma-next-generation sequencing and bioinformatics approaches. Medicina. 2019;55(12):768.","journal-title":"Medicina"},{"issue":"7","key":"2613_CR105","doi-asserted-by":"publisher","first-page":"e2112696119","DOI":"10.1073\/pnas.2112696119","volume":"119","author":"N Kong","year":"2022","unstructured":"Kong N, Zhang R, Wu G, Sui X, Wang J, Kim NY, Blake S, De D, Xie T, Cao Y. Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer. Proc Natl Acad Sci. 2022;119(7):e2112696119.","journal-title":"Proc Natl Acad Sci"},{"key":"2613_CR106","doi-asserted-by":"publisher","first-page":"949704","DOI":"10.3389\/fbioe.2022.949704","volume":"10","author":"M Shahidi","year":"2022","unstructured":"Shahidi M, Abazari O, Dayati P, Bakhshi A, Zavarreza J, Modarresi MH, Haghiralsadat F, Rahmanian M, Naghib SM, Tofighi D. Multicomponent siRNA\/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy. Front Bioeng Biotechnol. 2022;10:949704.","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"2613_CR107","first-page":"433","volume":"6","author":"Y Liang","year":"2021","unstructured":"Liang Y, Wang Y, Wang L, Liang Z, Li D, Xu X, Chen Y, Yang X, Zhang H, Niu H. Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer. Bioact Mater. 2021;6(2):433\u201346.","journal-title":"Bioact Mater"},{"issue":"19","key":"2613_CR108","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1158\/0008-5472.CAN-12-1871","volume":"72","author":"MR Kang","year":"2012","unstructured":"Kang MR, Yang G, Place RF, Charisse K, Epstein-Barash H, Manoharan M, Li L-C. Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Can Res. 2012;72(19):5069\u201379.","journal-title":"Can Res"},{"issue":"9","key":"2613_CR109","doi-asserted-by":"publisher","first-page":"eaaw6499","DOI":"10.1126\/sciadv.aaw6499","volume":"5","author":"J Liu","year":"2019","unstructured":"Liu J, Zhang Y, Zeng Q, Zeng H, Liu X, Wu P, Xie H, He L, Long Z, Lu X. Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes. Sci Adv. 2019;5(9):eaaw6499.","journal-title":"Sci Adv"},{"issue":"11","key":"2613_CR110","doi-asserted-by":"publisher","first-page":"e112713","DOI":"10.1371\/journal.pone.0112713","volume":"9","author":"H Guo","year":"2014","unstructured":"Guo H, Yan D, Wei Y, Han S, Qian H, Yang Y, Zhang Y, Liu X, Sun S. Inhibition of murine bladder cancer cell growth in vitro by photocontrollable siRNA based on upconversion fluorescent nanoparticles. PLoS ONE. 2014;9(11):e112713.","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"2613_CR111","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.4111\/icu.2016.57.S1.S60","volume":"57","author":"H Enokida","year":"2016","unstructured":"Enokida H, Yoshino H, Matsushita R, Nakagawa M. The role of microRNAs in bladder cancer. Investig Clin Urol. 2016;57(Suppl 1):S60\u201376.","journal-title":"Investig Clin Urol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02613-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:25:24Z","timestamp":1741271124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02613-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":111,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02613-8","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"56"}}